The Global Urolithiasis Management Devices market was valued at USD 1,531.08 million in 2021, growing at a CAGR of 4.27% during the forecast period from 2022 to 2027 to reach USD 1,963.12 million by 2027. The Urolithiasis Management Devices market is witnessing positive growth owing to the rising prevalence of urolithiasis or nephrolithiasis. In addition, sedentary lifestyle such as obesity which is a risk factor for the development of kidney stones, innovation in product design, increased risk of end-stage renal failure, growing geriatric population, and intensifying awareness for the procedure is thereby contributing to the growth of the Urolithiasis Management Devices market during the forecast period from 2022-2027.
Some of the key market players operating in the Urolithiasis Management Devices market include Boston Scientific Corporation, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., Walz Elektronik GmbH, DirexGroup, Medispec Ltd., Richard Wolf GmbH, STORZ MEDICAL AG, Olympus, General Electric Company (GE Healthcare), ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMIŃSKI S. A., ACE Medical Devices Pvt. Ltd., Siemens Healthcare Private Limited, Vimex Sp. z o.o., and others.
Urolithiasis Management Devices Overview
Urolithiasis Management Devices are devices used to manage Kidney stones (also called renal calculi, nephrolithiasis, or Urolithiasis) that form inside kidneys.
Discover more about the Urolithiasis Management Devices Report- Urolithiasis Management Devices Market Size
Recent Developments Activities in the Urolithiasis Management Devices Market
- In March 2021, Boston Scientific acquired Lumenis in a USD 1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urolithiasis Management Devices market.
- In March 2021, Dornier MedTech GmbH became the world’s first integrated urology company to be certified by the European Union’s Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier’s Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS™, a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.
- In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
According to DelveInsight, the Urolithiasis Management Devices Clinical Development Market would rise rapidly throughout the forecast period due to continuous commercial and clinical development.
Key Players Proactively working in the Urolithiasis Management Devices Market
In the Global Urolithiasis Management Devices Market Companies contribute significantly to their development and are also active in mergers and acquisitions to strengthen their market position. Some of the key market players operating in the Urolithiasis Management Devices market include Boston Scientific Corporation, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., Walz Elektronik GmbH, DirexGroup, Medispec Ltd., Richard Wolf GmbH, STORZ MEDICAL AG, Olympus, General Electric Company (GE Healthcare), ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMIŃSKI S. A., ACE Medical Devices Pvt. Ltd., Siemens Healthcare Private Limited, Vimex Sp. z o.o., and others.
Learn more about the Urolithiasis Management Devices, get in-depth information of the report offering- Urolithiasis Management Devices Market Outlook
Scope of the Urolithiasis Management Devices Market Report
- Coverage- Global
- Study Period- 2019-2027
- Urolithiasis Management Devices Market Companies- Boston Scientific Corporation (NYSE: BSX), EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., Walz Elektronik GmbH, DirexGroup, Medispec Ltd., Richard Wolf GmbH, STORZ MEDICAL AG, Olympus, General Electric Company (GE Healthcare) (NYSE: GE), ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (NYSE: UWCACZ), BK Medical Holding Company Inc., Hitachi Medical Systems (NYSE: HTHIY), Laborie, DRAMIŃSKI S. A., ACE Medical Devices Pvt. Ltd., Siemens Healthcare Private Limited (NYSE: SIEM), Vimex Sp. z o.o., and others.
- Urolithiasis Management Devices Market By Type (Diagnostics [X-Ray, Computed Tomography, Ultrasound, Others], Treatment [Shock Wave Lithotripters {Intracorporeal, Extracorporeal}, Ureteroscopes {Semi-Rigid, Flexible}, Stone Retrieval Devices, Others]
- Urolithiasis Management Devices Market By End-User (Hospitals, Ambulatory Surgical Centers, Others)
- Urolithiasis Management Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
- Porter’s Five Forces Analysis, Product Profiles, Cases Studies, KOL’s Views, and Analyst’s View
Table of Content
- Urolithiasis Management Devices Market Report Introduction
- Urolithiasis Management Devices Market Executive Summary
- Regulatory and Patent Analysis
- Urolithiasis Management Devices Market Key Factors Analysis
- Urolithiasis Management Devices Market Porter’s Five Forces Analysis
- COVID-19 Impact Analysis on Urolithiasis Management Devices Market
- Urolithiasis Management Devices Market Layout
- Urolithiasis Management Devices Market Global Company Share Analysis – Key 3-5 Companies
- Urolithiasis Management Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
Read More about the report offering- Urolithiasis Management Devices Market Companies
Key Takeaways from the Urolithiasis Management Devices Market Report Study
- Market size analysis for current Urolithiasis Management Devices market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urolithiasis Management Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global Urolithiasis Management Devices market.
- Various opportunities available for the other competitor in the Urolithiasis Management Devices market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current Urolithiasis Management Devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Urolithiasis Management Devices market growth in the coming future?
Latest Pharmaceuticals Market Research Reports by DelveInsight
Myopia Treatment Devices Market | Urology Ultrasounds Devices Market | Neurofibromatosis Type 1 Market | Liver Fibrosis Market | Oncolytic Virus Cancer Therapy Pipeline | Bone Growth Stimulators Market | Angio Suites Market | Moderate Psoriasis Market | Immune Thrombocytopenia Market | Brucellosis Market
Latest Blogs by DelveInsight
- Digital Twin Technology – Assessing the Growing Role and Its Evolving Applications in Healthcare Market
- What Factors are Shaping the Trends in the ARDS Market?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash
info@delveinsight.com